1. Home
  2. Directory
  3. Montana
  4. Bozeman
  5. Physical Medicine Rehabilitation
  6. NPI Profile
  7. Prescriptions 1821248089

ELBA YESI GERENA MALDONADO M.D.
Prescription History 1821248089
Physical Medicine & Rehabilitation - Neuromuscular Medicine in Bozeman, MT


Quality Rating: 79.6 out of 100 score

NPI Status: Active since September 24, 2008

Contact Information

3400 LARAMIE DR
BOZEMAN, MT
ZIP 59718
Phone: (406) 587-0122
Fax: (844) 656-2480

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ELBA YESI GERENA MALDONADO M.D., an active Neuromuscular Medicine specialist practicing in Bozeman, MT. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 314 documented patient claims. Among these therapy options, the most frequently utilized medication is Gabapentin, which accounts for 141 claims alone.

Medication Index

C
G
M
P
No matching medications currently found on file.

Calcitonin-Salmon

Generic Formulation: Calcitonin,salmon,syntheticSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.0
Days Supply 450
MT State Average Benchmarks
Peer Average Claims15.0
Peer Average 30-Day Fills16.8
Peer Average Days Supply496
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $820.52 across this reporting matrix range.

Provider Avg Cost Per Claim

$54.70

State Avg Cost Per Claim

$56.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat brittle bone disease (osteoporosis) in women who are at least 5 years past the change of life (menopause). Calcitonin works by slowing bone loss to help maintain strong bones and reduce your risk of fractures. This product has been withdrawn from the Canadian market due to safety problems.

Celecoxib

Generic Formulation: CelecoxibSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 22
30-Day Fills 22.0
Days Supply 660
MT State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills60.0
Peer Average Days Supply1,731
Conservative Utilization

This provider writes prescriptions for this formulation 38.9% less frequently than the standard regional baseline metric for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $787.31 across this reporting matrix range.

Provider Avg Cost Per Claim

$35.79

State Avg Cost Per Claim

$45.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.

Therapeutic Applications

This medication is a nonsteroidal anti-inflammatory drug (NSAID), specifically a COX-2 inhibitor, which relieves pain and swelling (inflammation). It is used to treat arthritis, acute pain, and menstrual pain and discomfort. The pain and swelling relief provided by this medication helps you perform more of your normal daily activities. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. This drug works by blocking the enzyme in your body that makes prostaglandins. Decreasing prostaglandins helps to reduce pain and swelling.

Gabapentin

Generic Formulation: GabapentinSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 141
30-Day Fills 141.0
Days Supply 4,133
MT State Average Benchmarks
Peer Average Claims77.0
Peer Average 30-Day Fills120.3
Peer Average Days Supply3,396
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 83.1% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $782.45 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.55

State Avg Cost Per Claim

$17.93

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Meloxicam

Generic Formulation: MeloxicamSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 83
30-Day Fills 94.7
Days Supply 2,840
MT State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills83.9
Peer Average Days Supply2,429
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 76.6% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $321.51 across this reporting matrix range.

Provider Avg Cost Per Claim

$3.87

State Avg Cost Per Claim

$5.59

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.

Therapeutic Applications

Meloxicam is used to help relieve moderate to severe pain. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling or pain.

Methylprednisolone

Generic Formulation: MethylprednisoloneSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 34
30-Day Fills 34.0
Days Supply 220
MT State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills22.7
Peer Average Days Supply188
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 54.5% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $419.98 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.35

State Avg Cost Per Claim

$10.88

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A PREDNISOLONE derivative with similar anti-inflammatory action.

Therapeutic Applications

Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders.

Pregabalin

Generic Formulation: PregabalinSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.0
Days Supply 570
MT State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills43.8
Peer Average Days Supply1,230
Conservative Utilization

This provider writes prescriptions for this formulation 44.1% less frequently than the standard regional baseline metric for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $198.61 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.45

State Avg Cost Per Claim

$36.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.

Therapeutic Applications

This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures).

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like ELBA YESI GERENA MALDONADO M.D. provides transparency into local medical care patterns within Bozeman, MT.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Neuromuscular Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.